Credential Securities’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
$375K Sell
2,030
-211
-9% -$37.3K 0.09% 128
2018
Q1
$382K Buy
2,241
+43
+2% +$7.89K 0.09% 133
2017
Q4
$382K Buy
2,198
+11
+0.5% +$1.95K 0.09% 140
2017
Q3
$407K Buy
2,187
+43
+2% +$7.62K 0.11% 133
2017
Q2
$370K Sell
2,144
-21
-1% -$3.42K 0.11% 138
2017
Q1
$355K Sell
2,165
-22
-1% -$3.66K 0.12% 137
2016
Q4
$320K Sell
2,187
-33
-1% -$4.97K 0.13% 138
2016
Q3
$370K Buy
2,220
+65
+3% +$11K 0.17% 134
2016
Q2
$328K Buy
2,155
+56
+3% +$8.71K 0.17% 133
2016
Q1
$315K Buy
2,099
+96
+5% +$14.3K 0.18% 131
2015
Q4
$325K Buy
2,003
+106
+6% +$16.7K 0.21% 118
2015
Q3
$262K Buy
+1,897
New +$299K 0.18% 117

Other funds holding AMGN

Credential Securities's AMGN Position: Q2 2018 in Review

Credential Securities reduced its Amgen (AMGN) stake by 9.4% in Q2 2018, selling an estimated $37.3K and leaving 2,030 shares worth $375K. The position accounts for 0.09% of the portfolio, ranked #128.

Credential Securities first reported a position in AMGN in Q3 2015 and has held it in 12 quarters since. The position peaked at $407K in Q3 2017. 1,764 funds tracked by Wall St. Rank hold AMGN as of Q2 2018.

  • Credential Securities held 2,030 shares of Amgen worth $375K as of Q2 2018.
  • Credential Securities sold 211 Amgen shares in Q2 2018, an estimated $37.3K.
  • Amgen made up 0.09% of Credential Securities's portfolio in Q2 2018, its #128 holding.
  • Credential Securities first reported a position in Amgen in Q3 2015 and has held it in 12 quarters since.
  • Credential Securities's Amgen position peaked at $407K in Q3 2017.
  • 1,764 funds tracked by Wall St. Rank held Amgen as of Q2 2018.

Based on Credential Securities's 13F filing for Q2 2018, filed 21 Jul 2025.